DC-SIGN与sIg-Mann结合促进滤泡性淋巴瘤细胞黏附与存活
经典滤泡性淋巴瘤(FL)中,表面免疫球蛋白抗原结合位点被寡甘露糖型聚糖占据(sIg-Mann),使结合从抗原转向DC-SIGN。DC-SIGN与sIg-Mann结合经B细胞受体近端激酶和肌动蛋白调节因子诱导FL细胞黏附于VCAM-1,且不引发凋亡,抗体阻断该接触可抑制原代FL细胞黏附和存活。
要点
- sIg-Mann与DC-SIGN结合诱导FL细胞黏附于VCAM-1,不诱导凋亡
- 抗DC-SIGN阻断抗体可抑制原代FL细胞的黏附和存活
- 该相互作用可能促进FL细胞滞留于淋巴结并支持存活
核心结论
- DC-SIGN与sIg-Mann特异性结合诱导FL细胞黏附于VCAM-1,并支持原代FL细胞存活。
- 抗DC-SIGN阻断抗体可抑制该黏附和存活,提示针对FL滞留与存活的早期治疗思路。
研究设计与样本
- 基于原代FL细胞与表达DC-SIGN的FDC来源YK6/SIGN细胞的体外研究。
主要发现
- sIg-Mann与DC-SIGN结合后,sIg-Mann形成比抗Ig刺激更宽且密度更低的簇,符合DC-SIGN诱导的内吞效率低和低水平胞内信号。
- 表达sIg-Mann的淋巴瘤细胞与表达DC-SIGN的细胞之间形成配体特异性细胞簇。
- DC-SIGN与sIg-Mann结合经B细胞受体近端激酶和肌动蛋白调节因子诱导FL细胞黏附于VCAM-1,方式类似抗Ig,但体外不引发凋亡。
- 抗体阻断sIg-Mann与FDC来源YK6/SIGN细胞上DC-SIGN的接触,可抑制原代FL细胞体外黏附和存活。
临床怎么用
- 抗DC-SIGN阻断抗体可能作为减少FL细胞在淋巴结微环境滞留与存活的早期治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The occupation of the surface immunoglobulin antigen-binding site by oligomannose-type glycans (sIg-Mann) is a tumor-specific posttranslational modification of classic follicular lymphoma (FL). SIg-Mann switches binding from antigen to dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN), which is expressed on interfollicular macrophages and FL-associated follicular dendritic cells (FDCs). The interaction with DC-SIGN induces reorganization of sIg-Mann in wider and less dense clusters than anti-Ig, consistent with inefficient DC-SIGN-induced endocytosis and low-level intracellular signaling. However, ligand-specific cell clusters form between sIg-Mann-expressing lymphoma cells and DC-SIGN-expressing cells, raising the need to understand the functional consequences of the interaction of DC-SIGN with sIg-Mann on primary FL cells. This engagement induces adhesion of FL cells to vascular cell adhesion molecule 1 (VCAM-1) via B-cell receptor-proximal kinases and actin regulators in a fashion similar to anti-Ig but without initiating apoptosis in vitro. Instead, antibody blockade of sIg-Mann contact with DC-SIGN, expressed on FDC-derived YK6/SIGN cells, inhibits adhesion and survival of primary FL cells in vitro. These data highlight that the specific interaction with DC-SIGN induces FL cell adhesion to VCAM-1, likely allowing FL cell retention in the lymph node and FL cell survival. Adhesion and survival are inhibited by an anti-DC-SIGN blocking antibody, indicating a new early therapeutic approach against FL retention and survival in adaptive tumor-tissue niches.
引用
- Chiodin G, Tatterton DJ, Rock P, et al. DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival. Blood. 2026. PMID: 41557914. doi:10.1182/blood.2025030049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。